CHU de Lille - Hopital Roger Salengro

Lille

1 studies enrolling now · 2 studies all time

What they study most

Alzheimer Disease, Amyotrophic Lateral Sclerosis

Studies at this site

• Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients — Recruiting now
• Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD) — Running, not enrolling